• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 144 filed by MetLife Inc.

    6/20/25 4:43:46 PM ET
    $MET
    Life Insurance
    Finance
    Get the next $MET alert in real time by email
    Form 144 Filer Information UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    Form 144

    NOTICE OF PROPOSED SALE OF SECURITIES
    PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933

    FORM 144

    144: Filer Information

    Filer CIK
    0000728618
    Filer CCC
    XXXXXXXX
    Is this a LIVE or TEST Filing? Radio button checked LIVE Radio button not checked TEST

    Submission Contact Information

    Name
    Phone
    E-Mail Address

    144: Issuer Information

    Name of Issuer
    METLIFE INC
    SEC File Number
    001-15787
    Address of Issuer
    200 Park Avenue
    New York
    NEW YORK
    10016
    Phone
    212-578-2211
    Name of Person for Whose Account the Securities are To Be Sold
    MetLife Separate Account SPI
    See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

    Relationship to Issuer
    Affiliate

    144: Securities Information

    Title of the Class of Securities To Be SoldName and Address of the BrokerNumber of Shares or Other Units To Be SoldAggregate Market ValueNumber of Shares or Other Units OutstandingApproximate Date of SaleName the Securities Exchange
    Common Stock
    Barclays Capital
    745 Seventh Ave
    New York � NY � 10019
    3602827867129782606/20/2025
    NYSE


    Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

    144: Securities To Be Sold

    Title of the ClassDate you AcquiredNature of Acquisition TransactionName of Person from Whom AcquiredIs this a Gift?Date Donor AcquiredAmount of Securities AcquiredDate of PaymentNature of Payment *
    Common Stock05/29/2015PurchaseGOLDMAN SACHSCheckbox not checked36006/03/2015Cash

    * If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



    Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

    144: Securities Sold During The Past 3 Months

    Name and Address of SellerTitle of Securities SoldDate of SaleAmount of Securities SoldGross Proceeds
    MetLife 401k Plan Trust-Large Cap Equity Index
    1 Metlife Way
    Whippany � NJ � 07981
    Common Stock03/21/202533527590.6
    Separate Account SPI
    1 Metlife Way
    Whippany � NJ � 07981
    Common Stock03/21/2025776341.72
    Separate Account II
    1 Metlife Way
    Whippany � NJ � 07981
    Common Stock03/21/2025473870.92
    Separate Account 149
    1 Metlife Way
    Whippany � NJ � 07981
    Common Stock03/21/20256494.16
    Separate Account II
    1 Metlife Way
    Whippany � NJ � 07981
    Common Stock06/13/202522117094.35

    144: Remarks and Signature

    Remarks
    Date of Notice
    06/20/2025

    ATTENTION:

    The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
    Signature
    Mirsad Usejnoski

    ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

    Get the next $MET alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $MET

    DatePrice TargetRatingAnalyst
    1/23/2025$97.00Market Perform
    BMO Capital Markets
    10/9/2024$97.00Buy
    TD Cowen
    9/5/2024$91.00Overweight
    Barclays
    1/8/2024$80.00Neutral → Buy
    Goldman
    11/17/2023$71.00Overweight
    Barclays
    10/5/2023$71.00Hold
    Deutsche Bank
    9/14/2023$58.00 → $72.00Hold → Buy
    Jefferies
    1/9/2023$80.00 → $78.00Buy → Neutral
    Goldman
    More analyst ratings

    $MET
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Johnson Jeh C. bought $879 worth of shares (17 units at $51.69) and was granted 19 shares, increasing direct ownership by 1% to 2,545 units (SEC Form 4)

    4 - METLIFE INC (0001099219) (Issuer)

    12/18/23 5:20:05 PM ET
    $MET
    Life Insurance
    Finance

    $MET
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    BMO Capital Markets initiated coverage on MetLife with a new price target

    BMO Capital Markets initiated coverage of MetLife with a rating of Market Perform and set a new price target of $97.00

    1/23/25 7:50:09 AM ET
    $MET
    Life Insurance
    Finance

    TD Cowen initiated coverage on MetLife with a new price target

    TD Cowen initiated coverage of MetLife with a rating of Buy and set a new price target of $97.00

    10/9/24 7:52:22 AM ET
    $MET
    Life Insurance
    Finance

    Barclays initiated coverage on MetLife with a new price target

    Barclays initiated coverage of MetLife with a rating of Overweight and set a new price target of $91.00

    9/5/24 8:14:53 AM ET
    $MET
    Life Insurance
    Finance

    $MET
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    MetLife Declares Third Quarter 2025 Preferred Stock Dividends

    MetLife, Inc. (NYSE:MET) today announced that it has declared the following preferred stock dividends: Quarterly dividend of $0.35263005 per share on the company's floating rate non-cumulative preferred stock, Series A, with a liquidation preference of $25 per share (NYSE:MET). Semi-annual dividend of $29.375 per share on the company's 5.875% fixed-to-floating rate non-cumulative preferred stock, Series D, with a liquidation preference of $1,000 per share. Quarterly dividend of $351.5625 per share on the company's 5.625% non-cumulative preferred stock, Series E, with a liquidation preference of $25,000 per share, represented by depositary shares each representing 1/1,000th interest

    8/15/25 4:15:00 PM ET
    $MET
    Life Insurance
    Finance

    MetLife CEO Michel Khalaf and CFO John McCallion to Speak at the 2025 Keefe, Bruyette & Woods Insurance Conference

    MetLife, Inc. (NYSE:MET) today announced that Michel Khalaf, president and chief executive officer, and John McCallion, executive vice president and chief financial officer, and head of MetLife Investment Management, will participate in a fireside chat at the 2025 Keefe, Bruyette & Woods Annual Insurance Conference on Wednesday, Sept. 3, 2025, from 10:05 a.m. to 10:45 a.m. (ET). A live audio webcast of the presentation will be available at https://event.summitcast.com/view/K8Qj6Ho6wvLLfFK2h5DE7w/n8bgBuwQnmybd6vjVT2Jmi. Those who want to listen should go to the website at least 15 minutes prior to the presentation to download and install any necessary software. A replay of the presentation

    8/13/25 4:15:00 PM ET
    $MET
    Life Insurance
    Finance

    MetLife Pet Insurance Named "Pet Insurance of the Year" In 2025 Pet Innovation Awards

    LOS ANGELES, Aug. 07, 2025 (GLOBE NEWSWIRE) -- The 2025 Pet Innovation Awards today announced that MetLife Pet Insurance (MetLife) has been selected as "Pet Insurance of the Year" in the 7th Annual Awards Program. The Pet Innovation Awards is an independent recognition platform highlighting the most innovative companies, services, and products in the highly competitive Pet Care industry. Pet owners are investing more in preventive health measures and MetLife offers the protection needed for all stages of a pet's life, including an optional preventive care coverage add-on. This add-on features coverage for flea and tick control, spay/neuter, heartworm prevention, teeth cleaning, vaccinat

    8/7/25 8:01:00 AM ET
    $MET
    Life Insurance
    Finance

    $MET
    SEC Filings

    View All

    MetLife Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - METLIFE INC (0001099219) (Filer)

    8/15/25 4:21:47 PM ET
    $MET
    Life Insurance
    Finance

    SEC Form 13F-HR filed by MetLife Inc.

    13F-HR - METLIFE INC (0001099219) (Filer)

    8/13/25 4:11:16 PM ET
    $MET
    Life Insurance
    Finance

    SEC Form 10-Q filed by MetLife Inc.

    10-Q - METLIFE INC (0001099219) (Filer)

    8/7/25 4:21:05 PM ET
    $MET
    Life Insurance
    Finance

    $MET
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Hubbard Robert Glenn was granted 964 shares, increasing direct ownership by 0.97% to 100,489 units (SEC Form 4)

    4 - METLIFE INC (0001099219) (Issuer)

    6/20/25 4:33:37 PM ET
    $MET
    Life Insurance
    Finance

    Director Johnson Jeh C. was granted 562 shares, increasing direct ownership by 9% to 6,789 units (SEC Form 4)

    4 - METLIFE INC (0001099219) (Issuer)

    6/20/25 4:33:17 PM ET
    $MET
    Life Insurance
    Finance

    Director Morrison Denise M was granted 562 shares, increasing direct ownership by 2% to 32,817 units (SEC Form 4)

    4 - METLIFE INC (0001099219) (Issuer)

    6/20/25 4:33:06 PM ET
    $MET
    Life Insurance
    Finance

    $MET
    Leadership Updates

    Live Leadership Updates

    View All

    MetLife Investment Management Agrees to Acquire Traditional Fixed Income and Equity Portfolio Management Teams Managing $6 Billion From Mesirow

    Acquisition includes high yield, strategic fixed income and small-cap equity teams MetLife Investment Management (MIM), the institutional asset management business of MetLife, Inc. (NYSE:MET), today announced that it has reached a definitive agreement to acquire three investment teams and assets managed by Mesirow, an independent, employee-owned financial services firm. MIM is acquiring the high yield and bank loan, strategic fixed income and small-cap equity teams and certain related investment products. Under the terms of the transaction, about $6 billion of assets managed by the acquired teams will transfer to MIM, subject to customary approvals and consents. The acquisition is consi

    1/8/25 8:30:00 AM ET
    $MET
    Life Insurance
    Finance

    MetLife Investment Management Names Kerry O'Brien Global Head of Insurance Asset Management and Liability Solutions

    MetLife Investment Management (MIM), the institutional asset management business of MetLife, Inc. (NYSE:MET), today announced that it has appointed Kerry O'Brien as global head of Insurance Asset Management and Liability Solutions. She will be responsible for the execution of investment strategies for the MetLife general account, helping drive growth in MIM's third-party insurance client channel as well as working with teams to drive liability solutions across other client segments. O'Brien will lead a team with an insurance investing heritage of nearly 150 years and an active role in managing MetLife's $414.1 billion general account as well as assets for third-party insurance clients. Sh

    12/2/24 8:30:00 AM ET
    $MET
    Life Insurance
    Finance

    MetLife Worldwide Benefits and GeoBlue® to Offer Joint Solution

    Combining the medical and ancillary strengths of two leading global carriers into a single solution -- Globaline™ MetLife and GeoBlue, the international solution for the Blue Cross® Blue Shield® companies, announced today they will offer a full suite of expatriate benefit products in a best-in-class single solution, Globaline™. Globaline™ brings together health coverage and services from GeoBlue – including medical, dental, vision, prescription, wellness, international employee assistance program and political and natural disaster assistance – and life, accidental death & dismemberment and long term disability coverage from MetLife Worldwide Benefits, including value-added services, such

    6/25/24 9:00:00 AM ET
    $MET
    Life Insurance
    Finance

    $MET
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by MetLife Inc.

    SC 13D/A - METLIFE INC (0001099219) (Subject)

    11/1/24 5:05:26 PM ET
    $MET
    Life Insurance
    Finance

    Amendment: SEC Form SC 13D/A filed by MetLife Inc.

    SC 13D/A - METLIFE INC (0001099219) (Subject)

    8/1/24 4:38:49 PM ET
    $MET
    Life Insurance
    Finance

    SEC Form SC 13D/A filed by MetLife Inc. (Amendment)

    SC 13D/A - METLIFE INC (0001099219) (Subject)

    5/2/24 5:34:57 PM ET
    $MET
    Life Insurance
    Finance

    $MET
    Financials

    Live finance-specific insights

    View All

    MetLife Declares Third Quarter 2025 Preferred Stock Dividends

    MetLife, Inc. (NYSE:MET) today announced that it has declared the following preferred stock dividends: Quarterly dividend of $0.35263005 per share on the company's floating rate non-cumulative preferred stock, Series A, with a liquidation preference of $25 per share (NYSE:MET). Semi-annual dividend of $29.375 per share on the company's 5.875% fixed-to-floating rate non-cumulative preferred stock, Series D, with a liquidation preference of $1,000 per share. Quarterly dividend of $351.5625 per share on the company's 5.625% non-cumulative preferred stock, Series E, with a liquidation preference of $25,000 per share, represented by depositary shares each representing 1/1,000th interest

    8/15/25 4:15:00 PM ET
    $MET
    Life Insurance
    Finance

    MetLife Announces 2Q 2025 Results

    MetLife, Inc. (NYSE:MET) today announced its second quarter 2025 results.   Earnings       Return     Per Share       on Equity (ROE)     2Q 2025       2Q 2025                         Net Income $1.03 ROE 11.7%                       Adjusted Earnings $2.02 Adjusted ROE 14.6% Net income was $698 million. Adjusted earnings declined to $1.4 billion, due to less favorable underwriting and lower investment margins, partially offset by volume growth and favorable expense margins. Premiums, fees and other revenues (PFOs) were $12.7 billion. Adjusted

    8/6/25 4:15:00 PM ET
    $MET
    Life Insurance
    Finance

    MetLife CFO John McCallion Provides Second Quarter 2025 Financial Update Video

    MetLife, Inc. (NYSE:MET) today announced that John McCallion, executive vice president and chief financial officer, and head of MetLife Investment Management, has provided a second quarter 2025 financial update video. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250806874930/en/ The video can be viewed on the company's website at https://www.metlife.com/about-us/newsroom/#video. About MetLife MetLife, Inc. (NYSE:MET), through its subsidiaries and affiliates ("MetLife"), is one of the world's leading financial services companies, providing insurance, annuities, employee benefits and asset management to help individual and i

    8/6/25 4:15:00 PM ET
    $MET
    Life Insurance
    Finance